SSA
MRVI icon

Schonfeld Strategic Advisors’s Maravai LifeSciences MRVI Stock Holding History

Schonfeld Strategic Advisors’s Portfolio MRVI Stock Details MRVI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-547,207
Closed -$1.21M – 2356
2025
Q1 		$1.21M Buy
547,207
+13,564
+3% +$53.6K 0.01% 1205
2024
Q4 		$2.91M Buy
533,643
+507,743
+1,960% +$3.27M 0.02% 693
2024
Q3 		$215K Buy
+25,900
New +$224K ﹤0.01% 1790
2024
Q2 		– Sell
-15,796
Closed -$137K – 2420
2024
Q1 		$137K Sell
15,796
-40,304
-72% -$273K ﹤0.01% 1818
2023
Q4 		$367K Buy
+56,100
New +$362K ﹤0.01% 1373
2023
Q3 		– Sell
-11,800
Closed -$147K – 2102
2023
Q2 		$147K Buy
+11,800
New +$159K ﹤0.01% 1650
2023
Q1 		– Sell
-35,528
Closed -$508K – 2432
2022
Q4 		$508K Buy
+35,528
New +$559K ﹤0.01% 1519
2022
Q2 		– Sell
-61,800
Closed -$2.18M – 2828
2022
Q1 		$2.18M Sell
61,800
-7,114
-10% -$238K 0.02% 701
2021
Q4 		$2.89M Buy
68,914
+55,904
+430% +$2.26M 0.03% 603
2021
Q3 		$639K Sell
13,010
-8,221
-39% -$401K 0.01% 1152
2021
Q2 		$886K Sell
21,231
-20,469
-49% -$793K 0.01% 968
2021
Q1 		$1.49M Buy
41,700
+21,005
+101% +$696K 0.02% 756
2020
Q4 		$580K Buy
+20,695
New +$576K 0.01% 995

Other funds holding MRVI

GL
GTCR LLC Chicago, Illinois $3.78B AUM 27.82% 1-Year Est. Return
1WCM
12 West Capital Management New York $592M AUM 40.75% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
MFS
Mirabella Financial Services London, United Kingdom $1.06B AUM 19.83% 1-Year Est. Return
PD
Point72 (DIFC) Dubai, United Arab Emirates $1.53B AUM 15.83% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Schonfeld Strategic Advisors's MRVI Position: Q2 2025 in Review

Schonfeld Strategic Advisors sold out of Maravai LifeSciences (MRVI) in Q2 2025, closing a stake of 547,207 shares — an estimated $1.21M sold.

Schonfeld Strategic Advisors first reported a position in MRVI in Q4 2020 and held it in 13 quarters. The position peaked at $2.91M in Q4 2024. 150 funds tracked by Wall St. Rank hold MRVI as of Q2 2025.

  • Schonfeld Strategic Advisors reported no remaining Maravai LifeSciences position as of Q2 2025 after selling out during the quarter.
  • Schonfeld Strategic Advisors sold 547,207 Maravai LifeSciences shares in Q2 2025, an estimated $1.21M.
  • Schonfeld Strategic Advisors first reported a position in Maravai LifeSciences in Q4 2020 and held it in 13 quarters.
  • Schonfeld Strategic Advisors's Maravai LifeSciences position peaked at $2.91M in Q4 2024.
  • 150 funds tracked by Wall St. Rank held Maravai LifeSciences as of Q2 2025.

Based on Schonfeld Strategic Advisors's 13F filing for Q2 2025, filed 14 Aug 2025.